×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

PROGRAMME:

Modérateurs: Fabrice Lécuru et Manuel Rodrigues
19:00
Spécificités des soins de support en ovaire : gestion de la carcinose symptomatique et pré-habilitation en néoadjuvant
Carole Bouleuc
 
 
19:15
Quel avenir à l’immunothérapie dans les cancers de l’ovaire ?
Audrey Bellesoeur
 
19:30
Traitement des récidives sous PARPi
Manuel Rodrigues
 
19:45
Chirurgie de la récidive : au-delà des essais GOG213, SOC1 & DESKTOP
Fabrice Lécuru
 
 
20:00
Débat/Discussion - Réponses aux questions
 
 
  
Shooting date : 2022-03-22
Last update : 2022-03-24
1 comment
Join the Discussion
  • johanne L. bonjour comment fait-on pour s inscrire ?

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, January 8th 2025 from 06:30pm to 07:45pm (GMT+1)
    Honolulu : Wednesday, January 8th 2025 from 06:30am to 07:45am (GMT+1)
    San Francisco : Wednesday, January 8th 2025 from 08:30am to 09:45am (GMT+1)
    New York : Wednesday, January 8th 2025 from 11:30am to 12:45pm (GMT+1)
    Buenos Aires : Wednesday, January 8th 2025 from 01:30pm to 02:45pm (GMT+1)
    London / Dublin : Wednesday, January 8th 2025 from 04:30pm to 05:45pm (GMT+1)
    Paris / Berlin : Wednesday, January 8th 2025 from 05:30pm to 06:45pm (GMT+1)
    Istanbul : Wednesday, January 8th 2025 from 06:30pm to 07:45pm (GMT+1)
    Moscou / Dubaï : Wednesday, January 8th 2025 from 08:30pm to 09:45pm (GMT+1)
    Bangkok : Wednesday, January 8th 2025 from 11:30pm to 12:45am (GMT+1)
    Shanghai : Thursday, January 9th 2025 from 12:30am to 01:45am (GMT+1)
    Tokyo : Thursday, January 9th 2025 from 01:30am to 02:45am (GMT+1)
    Sydney : Thursday, January 9th 2025 from 02:30am to 03:45am (GMT+1)
    Wellington : Thursday, January 9th 2025 from 04:30am to 05:45am (GMT+1)

    Bénéfices de la maintenance par iPARP en 1L du cancer de l’ovaire

    Share
    0
    Days
    0
    Hours
    0
    Minutes
    0
    Seconds
    Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
    Honolulu : Monday, April 28th 2025 from 06:30am to 07:30am (GMT+2)
    San Francisco : Monday, April 28th 2025 from 09:30am to 10:30am (GMT+2)
    New York : Monday, April 28th 2025 from 12:30pm to 01:30pm (GMT+2)
    Buenos Aires : Monday, April 28th 2025 from 01:30pm to 02:30pm (GMT+2)
    Reykjavik : Monday, April 28th 2025 from 04:30pm to 05:30pm (GMT+2)
    London / Dublin : Monday, April 28th 2025 from 05:30pm to 06:30pm (GMT+2)
    Paris / Berlin : Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
    Istanbul : Monday, April 28th 2025 from 07:30pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Monday, April 28th 2025 from 08:30pm to 09:30pm (GMT+2)
    Bangkok : Monday, April 28th 2025 from 11:30pm to 12:30am (GMT+2)
    Shanghai : Tuesday, April 29th 2025 from 12:30am to 01:30am (GMT+2)
    Tokyo : Tuesday, April 29th 2025 from 01:30am to 02:30am (GMT+2)
    Sydney : Tuesday, April 29th 2025 from 03:30am to 04:30am (GMT+2)
    Wellington : Tuesday, April 29th 2025 from 05:30am to 06:30am (GMT+2)

    PARPi dans le cancer de l'ovaire en 1L

    données actuelles et perspectives pour la combinaison avec l’IO

    Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, April 12th 2022 from 06am to 07:30am (GMT+2)
    San Francisco : Tuesday, April 12th 2022 from 09am to 10:30am (GMT+2)
    New York : Tuesday, April 12th 2022 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Tuesday, April 12th 2022 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Tuesday, April 12th 2022 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Tuesday, April 12th 2022 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Tuesday, April 12th 2022 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, April 12th 2022 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, April 12th 2022 from 08pm to 09:30pm (GMT+2)
    Bangkok : Tuesday, April 12th 2022 from 11pm to 12:30am (GMT+2)
    Shanghai : Wednesday, April 13th 2022 from 12am to 01:30am (GMT+2)
    Tokyo : Wednesday, April 13th 2022 from 01am to 02:30am (GMT+2)
    Sydney : Wednesday, April 13th 2022 from 03am to 04:30am (GMT+2)
    Wellington : Wednesday, April 13th 2022 from 05am to 06:30am (GMT+2)

    Cancers séreux de bas grade

    Share
    Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
    Honolulu : Wednesday, May 18th 2022 from 06:30am to 08am (GMT+2)
    San Francisco : Wednesday, May 18th 2022 from 09:30am to 11am (GMT+2)
    New York : Wednesday, May 18th 2022 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Wednesday, May 18th 2022 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Wednesday, May 18th 2022 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Wednesday, May 18th 2022 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
    Istanbul : Wednesday, May 18th 2022 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Wednesday, May 18th 2022 from 08:30pm to 10pm (GMT+2)
    Bangkok : Wednesday, May 18th 2022 from 11:30pm to 01am (GMT+2)
    Shanghai : Thursday, May 19th 2022 from 12:30am to 02am (GMT+2)
    Tokyo : Thursday, May 19th 2022 from 01:30am to 03am (GMT+2)
    Sydney : Thursday, May 19th 2022 from 03:30am to 05am (GMT+2)
    Wellington : Thursday, May 19th 2022 from 05:30am to 07am (GMT+2)

    Importance de la chimio-sensibilité dans la prise en charge des cancers de l’ovaire

    Share
    Scroll Up